Goldberg J F, Burdick K E
Weill Medical College of Cornell University and the Bipolar Disorders Research Clinic, Payne Whitney Clinic-New York Presbyterian Hospital, New York, USA.
J Clin Psychiatry. 2001;62 Suppl 14:27-33.
The increasing use of anticonvulsant drugs in psychiatry has prompted greater awareness of their effects on a range of psychiatric domains, including cognition. Older versus newer antiepileptic drugs have been reported to either worsen or enhance cognitive performance in clinical populations, and the extent to which cognitive disturbances may reflect iatrogenic factors versus psychopathology is subject to debate. We review current information about the role of anticonvulsants in cognition, with particular emphasis on newer compounds (such as lamotrigine, gabapentin, and topiramate), the cognitive dimensions of affective illness, and the clinical approach to evaluating cognition in psychiatric patients taking anticonvulsant drugs over time.
抗惊厥药物在精神病学领域的使用日益增加,这促使人们更加关注其对包括认知在内的一系列精神领域的影响。据报道,在临床人群中,较老的抗癫痫药物与较新的抗癫痫药物相比,要么会使认知表现恶化,要么会增强认知表现,而认知障碍在多大程度上反映医源性因素与精神病理学仍存在争议。我们回顾了关于抗惊厥药物在认知方面作用的当前信息,特别强调了较新的化合物(如拉莫三嗪、加巴喷丁和托吡酯)、情感障碍的认知维度,以及随着时间推移对服用抗惊厥药物的精神病患者进行认知评估的临床方法。